Skip to content

Medi-Cal: reimbursement: blood factors.

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

CA SB 525 · Senate Bill · 2019–2020

Stage
Session ended
Started in
Senate
Sponsor
Stone
Latest action
Feb 3, 2020

What it does

Existing law provides for the Medi-Cal program, which is administered by the State Department of Health Care Services, under which qualified low-income individuals receive health care services. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Existing law provides for a schedule of benefits covered by the Medi-Cal program, including the purchase of prescribed drugs subject to the Medi-Cal list of contract drugs and utilization controls. Existing law authorizes the department to enter into contracts with manufacturers of drugs, to maintain a list of contract drugs, including blood factors, and to require pharmaceutical manufacturers to provide…

Read the full text

Where it stands

This bill did not become law and its session has ended, so it can no longer move. It would have to be reintroduced.

  1. Introduced (Current step)

    Introduced · Feb 3, 2020

  2. Committee (Needs attention)

    The session ended first

  3. Floor (Not started)

  4. Law (Not started)

What moved

Loading recorded actions…

Who is involved

Sponsors

The lawmakers who put their names on it, lead sponsors first.

  • StoneLead sponsor

In the news

Reporting that may mention this subject. Possible matches are labeled.

Loading coverage…

Work with this bill

Medi-Cal: reimbursement: blood factors. | 52